Thursday | 06 Oct 2022

Mediterranean MSMEs face important challenges in terms of competitiveness, sustainability, internationalization and capacity to innovate while urgent measures are needed to tackle common environmental challenges and untap the potential of both natural and cultural heritage to contribute to sustainable growth and economic development.

Against this backdrop, the INVESTEMD project aims at addressing both economic and environmental challenges, by supporting new, sustainable business opportunities for young people and women in three Mediterranean Partner Countries: Egypt, Lebanon and Tunisia.

The INVESTMED Project is co-funded by the European Union under the ENI CBC Mediterranean Sea Basin Programme 2014-2020. INVESTMED will have an impact on MSMEs, start-ups and recently established enterprises where staff will be trained and coached to become more sustainable and competitive and financially supported via an open competition. Specific business incubation services will also be established for sustainable start-ups as well while relevant public authorities will benefit from capacity building and exchange of best practices to facilitate access and protect IPR for MSMEs.

Link to project website: http://www.enicbcmed.eu/projects/investmed

Facebook: https://www.facebook.com/InvestmedEU

Twitter: https://twitter.com/InvestmedP

[trx_sc_button buttons=”%5B%7B%22type%22%3A%22default%22%2C%22size%22%3A%22normal%22%2C%22color_style%22%3A%22default%22%2C%22link%22%3A%22https%3A%2F%2Feuromed-economists.org%2Finvestmed%2Finvestmed-call-sbm-training%2F%22%2C%22title%22%3A%22INVESTMED%3A%20Call%20for%20trainees%20in%20Sustainable%20Business%20Management%20in%20Egypt%2C%20Lebanon%20and%20Tunisia%20-%20Deadline%2021%20July%202021%22%2C%22text_align%22%3A%22none%22%2C%22icon_position%22%3A%22left%22%7D%5D” hide_on_wide=”” hide_on_desktop=”” hide_on_notebook=”” hide_on_tablet=”” hide_on_mobile=””]

INVESTMED has a duration of 30 months, with a total budget of 3.8 Million euro, of which 3.4 Million euro are funded by ENI CBC MED (90%).